Coric Vlad
SEC insider (Form 3/4/5 filer). CIK 0001704317. Director at Royalty Pharma plc (RPRX) and 3 other issuers. 25 reported Form 4/5 transactions since Sep 2024; latest on Jun 5, 2026. Located in NEW YORK, NY.
Companies Coric Vlad has filed insider reports for
- Royalty Pharma plc (RPRX): Director
- Biohaven Ltd. (BHVN): Director, Officer, Chief Executive Officer
- Veradermics, Inc (MANE): Director
- Revance Therapeutics, Inc. (RVNC): Director
Coric Vlad
CIK: 0001704317
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (25 total)
- Jun 5, 2026RPRX
Royalty Pharma plc
AwardDirect4.5K shares- - Feb 27, 2026BHVN
Biohaven Ltd.
AwardDirectStock Options (Right to buy)
550K shares- - Feb 5, 2026MANE
Veradermics, Inc
PurchaseIndirect58.8K shares at avg. $17.00$1000K - Feb 5, 2026MANE
Veradermics, Inc
ConversionIndirect78.1K shares- - Feb 5, 2026MANE
Veradermics, Inc
ConversionIndirect148.8K shares- - Feb 5, 2026MANE
Veradermics, Inc
ConversionIndirect33.7K shares- - Feb 5, 2026MANE
Veradermics, Inc
ConversionIndirect148.8K shares- - Feb 5, 2026MANE
Veradermics, Inc
ConversionIndirect78.1K shares- - Feb 5, 2026MANE
Veradermics, Inc
ConversionIndirect33.7K shares- - Feb 5, 2026MANE
Veradermics, Inc
ConversionDirect117.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 5, 2026 |  RPRX Royalty Pharma plc | Award | 4,545 | - | $0 | Direct |
| Feb 27, 2026 |  BHVN Biohaven Ltd. | Award Stock Options (Right to buy) | 550,000 | - | - | Direct |
| Feb 5, 2026 |  MANE Veradermics, Inc | Purchase | 58,823 | $17.00 | $999,991 | Indirect |
| Feb 5, 2026 | MANE Veradermics, Inc | Conversion | 78,075 | - | $0 | Indirect |
| Feb 5, 2026 | MANE Veradermics, Inc | Conversion | 148,794 | - | $0 | Indirect |
| Feb 5, 2026 | MANE Veradermics, Inc | Conversion | 33,706 | - | $0 | Indirect |
| Feb 5, 2026 | MANE Veradermics, Inc | Conversion | 148,794 | - | $0 | Indirect |
| Feb 5, 2026 | MANE Veradermics, Inc | Conversion | 78,075 | - | $0 | Indirect |
| Feb 5, 2026 | MANE Veradermics, Inc | Conversion | 33,706 | - | $0 | Indirect |
| Feb 5, 2026 | MANE Veradermics, Inc | Conversion | 117,112 | - | $0 | Direct |
1-10 of 25 transactions